top of page

1999 Wylie Scholar

  • Writer: Angela Ramirez
    Angela Ramirez
  • Oct 9
  • 1 min read

ree

Richard Powell, MD

Section Chief, Vascular Surgery Dartmouth‐Hitchcock Medical Center

Professor of Surgery & Professor of Radiology

Geisel School of Medicine, Dartmouth


Wylie Research Focus: Multiple national stem cell therapy and plasmid gene therapy trials for the treatment of critical limb ischemia

Date Awarded: 1999


“My greatest accomplishment was becoming section chief of vascular surgery at Dartmouth and facilitating the research careers of the faculty in our section. I have secured approximately $8 million in additional funding since receiving the Wylie award.”

Dr. Powell is currently the principal investigator for multiple national stem cell therapy and plasmid gene therapy trials for the treatment of critical limb ischemia. He is also principal investigator for a study to evaluate adding a drug to standard of care treatment to reduce the incidence of clots and complications of the heart, brain or legs due to procedure(s) to improve the blood flow of legs.


Dr. Powell’s research for the Wylie Scholar award laid the foundation for further studies in atherosclerosis, growing new blood vessels (angiogenesis), and re-narrowing of a blood vessel after angioplasty and stenting. His work involved investigating blood vessel dysfunction and growth to treat ischemic heart disease and critical limb ischemia.


Dr. Powell’s Wylie Scholar award led to obtaining multiple NIH grants, building a vascular research laboratory at Dartmouth‐Hitchcock Medical Center, and becoming Section Chief of Vascular Surgery.

Comments


Connect with us for more information

274 Redwood Shores Parkway #717
Redwood City, CA 94065
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Vascular Cures Media

  • Instagram

CHAMPIONS Social Media

Foundation+to+Advance+Cures_National+Health+Information+Award.webp

Foundation to Advance Vascular Cures is a tax-exempt, nonprofit organization tax ID#: 94-2825216 as described in the Section 501(c)(3) of the Internal Revenue Code. Donations are tax deductible.
Copyright © 2024 Foundation to Advance Vascular Cures. All rights reserved.

bottom of page